ロード中...
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use(1)(2)(3)(4)
Background: Genetic susceptibility testing for Alzheimer disease (AD) with APOE genotype disclosure is not recommended for clinical use but is available through direct-to-consumer (DTC) genetic testing companies. Little is known about whether APOE genotype disclosure would actually prompt changes in...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Nutrition
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2854909/ https://ncbi.nlm.nih.gov/pubmed/20219963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3945/ajcn.2009.28981 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|